Research Analysts at Jefferies Increased Humana (NYSE:HUM) from Hold to Buy Rating

Share with your friends


Jefferies Co Analyst Rating Change Humana NYSE:HUM

Humana (NYSE:HUM) Change of Rating

Trading of Humana (NYSE:HUM)’s shares is going to be interesting today. Jefferies boosted the stock from a Hold to a Buy.

In spite of this stock rating upgrade NYSE:HUM is at the moment trading -0.40% lower at $242.59 as of 10:05 AM New York time. Humana shares have [From2] 0% over the past 200 days, while the S&P 500 Index has increased 6.00% in the same time period.

Out of 15 brokers covering Humana, 6 rate it a Buy, 13 indicate a Hold while 0 suggest a Sell. The highest target is $230 and the lowest is $176.93 according to Thomson/First Call. The 12-month mean target is $205.93, which means downside potential of 15.11% over the current price.

Institutional Ownership

Glenview Capital Management Llc had the most significant stake with ownership of 9.53 million shares as of q2 2015 for 12.06% of the stocks portfolio. Jet Capital Investors L P is another very bullish investment manager who is owning 719,209 shares of Humana or 8.97% of their stocks portfolio. Also, Fort L.P. have 7.25% of their stocks portfolio invested in the company for 118,950 shares. The New York-based fund Clovis Capital Management Lp revealed it had acquired so far a stake worth about 4.8% of the investment manager’s stock portfolio in Humana. The New York-based fund Arrowgrass Capital Partners (Us) Lp is also positive about the stock, possessing 86,460 shares or 4.66% of their stocks portfolio.

Humana (NYSE:HUM) Profile

Humana IncHumana Inc. is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Humana (NYSE:HUM) traded down -0.40% on 12 January, hitting $242.59. A total of 1.74M shares of the company’s stock traded hands. This is up from average of 1.22M shares. Humana has a 52 week low of $186.25 and a 52 week high of $264.56. The company has a market cap of $34.80B and a P/E ratio of 19.17.

Get the latest Humana (NYSE:HUM) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.